Table 2 Pathway enrichment results for T cells
| Â | group | Description | pvalue | ratio |
|---|---|---|---|---|
GO:0002181…1 | C1 | cytoplasmic translation | ################## | 13.80145278 |
GO:0022613…2 | C1 | ribonucleoprotein complex biogenesis | 9.8571405619293E-11 | 8.958837772 |
GO:0042254…3 | C1 | ribosome biogenesis | ################## | 6.779661017 |
GO:1,903,039 | C1 | positive regulation of leukocyte cell–cell adhesion | ################## | 6.295399516 |
GO:0006119 | C1 | oxidative phosphorylation | ################## | 4.600484262 |
GO:1,903,131 | C2 | mononuclear cell differentiation | ################## | 9.947643979 |
GO:0002573 | C2 | myeloid leukocyte differentiation | ################## | 6.806282723 |
GO:0030098 | C2 | lymphocyte differentiation | ################## | 8.90052356 |
GO:0046631 | C2 | alpha–beta T cell activation | ################## | 5.759162304 |
GO:0030099 | C2 | myeloid cell differentiation | ################## | 8.90052356 |
GO:0002181…11 | C3 | cytoplasmic translation | ################## | 56.66666667 |
GO:0022613…12 | C3 | ribonucleoprotein complex biogenesis | 1.3609964816541E-10 | 36.66666667 |
GO:0042255 | C3 | ribosome assembly | ################## | 20 |
GO:0042254…14 | C3 | ribosome biogenesis | ################## | 30 |
GO:0022618 | C3 | protein-RNA complex assembly | ################## | 26.66666667 |
GO:1,902,175 | C4 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | ################## | 5.494505495 |
GO:0098869 | C4 | cellular oxidant detoxification | ################## | 6.593406593 |
GO:0007566 | C4 | embryo implantation | ################## | 5.494505495 |
GO:1,904,851 | C4 | positive regulation of establishment of protein localization to telomere | ################## | 3.296703297 |
GO:0006457 | C4 | protein folding | ################## | 8.791208791 |
GO:0008380 | C5 | RNA splicing | ################## | 7.819905213 |
GO:0000377 | C5 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.8781467157288E-12 | 5.568720379 |
GO:0000398 | C5 | mRNA splicing, via spliceosome | 3.8781467157288E-12 | 5.568720379 |
GO:0000375 | C5 | RNA splicing, via transesterification reactions | ################## | 5.568720379 |
GO:0016032 | C5 | viral process | ################## | 5.805687204 |
GO:0042267 | C6 | natural killer cell mediated cytotoxicity | 1.7393351392931E-05 | 23.07692308 |
GO:0002228 | C6 | natural killer cell mediated immunity | ################## | 23.07692308 |
GO:0001732 | C6 | formation of cytoplasmic translation initiation complex | ################## | 15.38461538 |
GO:0002449 | C6 | lymphocyte mediated immunity | ################## | 30.76923077 |
GO:0001909 | C6 | leukocyte mediated cytotoxicity | 0.000117358 | 23.07692308 |
GO:0002757 | C7 | immune response-activating signaling pathway | ################## | 17.3553719 |
GO:0002768 | C7 | immune response-regulating cell surface receptor signaling pathway | 1.2671190772334E-09 | 13.2231405 |
GO:0002429 | C7 | immune response-activating cell surface receptor signaling pathway | 3.464850660679E-09 | 12.39669421 |
GO:0002366 | C7 | leukocyte activation involved in immune response | ################## | 11.57024793 |
GO:0002263 | C7 | cell activation involved in immune response | 9.7815141145771E-09 | 11.57024793 |